{"title":"Digital hypertension - what we need for the high-quality management of hypertension in the new era.","authors":"Kazuomi Kario, Kei Asayama, Hisatomi Arima, Chisa Matsumoto, Naoki Nakagawa, Akihiro Nomura, Michihiro Satoh, Keisuke Shinohara, Naoko Tomitani, Koichi Yamamoto, Satoshi Hoshide","doi":"10.1038/s41440-025-02307-8","DOIUrl":null,"url":null,"abstract":"<p><p>Digital technologies are playing an increasing role in hypertension management. Digital hypertension is a new field that integrates advancing technologies into hypertension management. This research area encompasses various aspects of digital transformation technologies, including the development of novel blood pressure (BP) measurement devices-whether cuffless or cuff-based sensors-the transmission of large-scale time-series BP data, cloud-based computing and analysis of BP indices, presentation of the results, and feedback systems for both patients and physicians. A key component of this approach is novel blood pressure (BP) monitoring devices. This article summarizes the latest information and discussions about \"held at the 2024 Japan Society of Hypertension scientific meeting. Novel BP monitoring includes cuffless devices that estimate BP, but cuffless devices require achieving accuracy without the need for calibration using conventional cuff-based devices. New BP monitoring devices can provide information on novel biomarkers beyond BP and may improve risk assessment and outcomes. Integration of BP data with omics and clinical information should enable personalized hypertension management. Key data gaps relating to novel BP monitoring devices are accuracy/validation in different settings/populations, association between BP metrics and hard clinical outcomes, and measurement/interpretation of BP variability data. Human- and health system-related factors also need to be addressed or overcome before these devices can be successfully integrated into routine clinical practice. If these things can be achieved, new BP monitoring technologies could transform hypertension management and play a pivotal role in the future of remote healthcare. This article summarizes the latest information and discussions about digital hypertension from the Digital Hypertension symposium that took place during the 2024 Japan Society of Hypertension scientific meeting.</p>","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":" ","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hypertension Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41440-025-02307-8","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Digital technologies are playing an increasing role in hypertension management. Digital hypertension is a new field that integrates advancing technologies into hypertension management. This research area encompasses various aspects of digital transformation technologies, including the development of novel blood pressure (BP) measurement devices-whether cuffless or cuff-based sensors-the transmission of large-scale time-series BP data, cloud-based computing and analysis of BP indices, presentation of the results, and feedback systems for both patients and physicians. A key component of this approach is novel blood pressure (BP) monitoring devices. This article summarizes the latest information and discussions about "held at the 2024 Japan Society of Hypertension scientific meeting. Novel BP monitoring includes cuffless devices that estimate BP, but cuffless devices require achieving accuracy without the need for calibration using conventional cuff-based devices. New BP monitoring devices can provide information on novel biomarkers beyond BP and may improve risk assessment and outcomes. Integration of BP data with omics and clinical information should enable personalized hypertension management. Key data gaps relating to novel BP monitoring devices are accuracy/validation in different settings/populations, association between BP metrics and hard clinical outcomes, and measurement/interpretation of BP variability data. Human- and health system-related factors also need to be addressed or overcome before these devices can be successfully integrated into routine clinical practice. If these things can be achieved, new BP monitoring technologies could transform hypertension management and play a pivotal role in the future of remote healthcare. This article summarizes the latest information and discussions about digital hypertension from the Digital Hypertension symposium that took place during the 2024 Japan Society of Hypertension scientific meeting.
期刊介绍:
Hypertension Research is the official publication of the Japanese Society of Hypertension. The journal publishes papers reporting original clinical and experimental research that contribute to the advancement of knowledge in the field of hypertension and related cardiovascular diseases. The journal publishes Review Articles, Articles, Correspondence and Comments.